medicaltreatment:chemo

  • Eleanor Draeger: We have reached the point where we should consider compulsory vaccination - The BMJ
    https://blogs.bmj.com/bmj/2019/05/17/eleanor-draeger-we-have-reached-the-point-where-we-should-consider-compul

    The time for gently nudging parents to vaccinate their children is over. A groundswell of antivaccine opinion and fake news from a highly influential and malicious antivax lobby is managing to harness social media for its own ends. As a result, in the UK, uptake of measles, mumps, and rubella (MMR) vaccine has fallen to below the level needed to create herd immunity. Vaccination coverage is currently 91% across the UK, which falls short of the 95% that is needed for herd immunity. This is putting the most vulnerable children in our society at risk. For there are some children who cannot have the MMR vaccine—either because they are too young or because they have a medical condition that means that it is not safe for them to have a live vaccine. This includes children with cancer, who cannot have the vaccine while they are being treated with chemotherapy because they are immunosuppressed.

    #vaccination #vaccins #santé

  • How to Win the War on Cancer - YouTube
    https://www.youtube.com/watch?v=l_C26gt1LbA

    How effective is chemotherapy for colon, lung, breast, and prostate cancer?

    https://nutritionfacts.org/video/how-to-win-the-war-on-cancer

    If you look at the contribution of cancer-killing chemo to five-year survival in cancer patients, it’s on the order of only about 2%. Now, there’s some pediatric cancers we’ve gotten good at treating, and testicular cancer and Hodgkin’s disease are exceptions, but if you look at our most common cancers—colon, lung, breast, and prostate—the success rate is only about 1%. Meaning like, out of nearly 14,000 colon cancer patients, only 146 lived out five years thanks to chemotherapy. So, the chance of survival benefit is like one in a hundred, but doctors don’t tell patients that. “…[N]ew chemotherapy drug[s are] promoted as…major breakthrough[s], only to be later [quietly] rejected.” “The minimal impact on survival in the more common cancers conflicts with the perceptions of many patients who feel they are receiving a treatment that will significantly enhance their chances of cure.”

    #cancer #chimiothérapie #prévention #nutritionfacts

  • Why #cbd Needs to be Part of Your Medical Regimen
    https://hackernoon.com/why-cbd-needs-to-be-part-of-your-medical-regimen-2ba8c5329b52?source=rss

    In a world where prescriptions are king and synthetic pharmaceuticals rule the medical community, finding reliable natural or homeopathic remedies can be a challenge. However for patients who have not found solutions for their conditions from “traditional” treatment, CBD, or Cannabidiol, has been something of a miracle cure. Reacting directly with the serotonin receptors in the body, CBD helps restore these natural neurotransmitters, helping the body to help itself.For individuals who suffer from minor motion sickness, chronic vertigo, and even chemotherapy related nausea, CBD treats these symptoms effectively and safely. One in four cancer patients, traditional treatments to manage nausea and vomiting have little to no effect. In these individuals, doses of CBD have been shown to (...)

    #cbd-oils #health #cannabis #infographics

  • Breast #cancer : Test means fewer women will need chemotherapy - BBC News
    https://www.bbc.com/news/health-44347381

    Currently, women who get a low score on the test are told they do not need chemo, those with a high score are told they definitely do.

    But most women get an intermediate result meaning they are unclear as to what to do.

    Data presented at the world’s biggest meeting of cancer doctors and scientists in Chicago shows these women have the same survival rates with or without chemo.

    The nine-year-survival-rate was 93.9% without chemotherapy and 93.8% with chemotherapy.

    [...]

    The study is strictly about early stage breast cancers - specifically those that can still be treated with hormone therapy, have not spread to the lymph nodes and do not have the HER2 mutation, which makes them grow more quickly.

    The test is performed on a sample of the tumour when it is removed during surgery.

    It works by looking at the activity levels of 21 genes, which are markers of how aggressive the cancer is.

    #Cancer_du_sein : des milliers de femmes pourront demain éviter la #chimiothérapie | E-#Santé
    http://www.e-sante.fr/cancer-du-sein-des-milliers-de-femmes-pourront-demain-eviter-la-chimiotherapie/breve/61546

  • Do Mammograms Save Lives ? - YouTube
    https://www.youtube.com/watch?v=GTnC1P4XOF0

    (Le sous-titrage existe en français)

    For every life saved by mammography, as many as 2 to 10 women are overdiagnosed, meaning turned into breast cancer patients unnecessarily, along with all the attendant harms of chemo, radiation, or surgery without the benefits.

    Sources et transcription : https://nutritionfacts.org/video/do-mammograms-save-lives

    #mammographies #cancer #mastectomie #surdiagnostic

    À rapprocher de https://seenthis.net/messages/637162 et https://seenthis.net/messages/634803

    • À noter que c’est la 4è vidéo d’une série de 14 (à venir).
      La liste et les liens vers les vidéos, lorsqu’elles sortiront se trouvent sur la première vidéo là : https://nutritionfacts.org/video/9-out-of-10-women-misinformed-about-mammograms

      https://youtu.be/dfOdps2bppY

      I think I do a pretty good job in the video explaining why I decided to take on this topic. There’s just so much confusion, combined with the corrupting commercial interests of a billion-dollar industry. As with any important health decision, everyone should be fully informed of the risks and benefits, and make up their own mind about their own bodies. That’s why I created this 14-part video series.

      [...] Stay tuned for the rest of the videos in this 14-part series, which will come out over the next month and a half:

      – Mammogram Recommendations – Why the Conflicting Guidelines?
      – Should Women Get Mammograms Starting at Age 40?
      – Do Mammograms Save Lives?
      – Consequences of False-Positive Mammogram Results
      – Do Mammograms Hurt?
      – Can Mammogram Radiation Cause Breast Cancer?
      – Understanding the Mammogram Paradox
      – Overtreatment of Stage 0 Breast Cancer DCIS
      – Women Deserve to Know the Truth About Mammograms
      – Breast Cancer & the 5-Year Survival Rate Myth
      – Why Mammograms Don’t Appear to Save Lives
      – Why Patients Aren’t Informed About Mammograms
      – The Pros & Cons of Mammograms

    • Ce n’est pas la mammographie qui est mortelle, ce qui est grave, c’est d’être dépossédée de son corps et de sa santé, de ne pas avoir le choix, c’est le stress induit par l’annonce du cancer, ce sont les traitements : intervention chirurgicale, mutilation, chimiothérapie, radiothérapie, mais aussi l’isolement et les tabous d’une longue maladie.
      Mais pas le dépistage.
      Quelle image prendre si ce n’est celle d’une piste inconnue ?
      On envoie l’éclaireuse, elle repère (ou pas) une crasse, analyse et prévient des risques, et il n’en va pas de sa responsabilité si ensuite on propose d’envoyer l’artillerie lourde.
      Mais là, c’est le niveau d’angoisse que personne ne soigne jamais.
      Maintenant, je ne sais pas pourquoi l’information tourne uniquement autour du surdiagnostic, il y a un espace de silence mensonger que je n’arrive pas à cerner.
      Il me semble qu’il faut aider les femmes à comprendre, pas à renoncer à savoir, et évidemment leur permettre d’éviter les opérations qui ne sont pas nécessaires.

  • This Man’s Immune System Got a Cancer-killing Update - Facts So Romantic
    http://nautil.us/blog/this-mans-immune-system-got-a-cancer_killing-update

    William Ludwig was almost dead when he became Patient Number One in a radical new cancer treatment, one that’s just won the endorsement of F.D.A. advisors.Photograph by sebastianosecondi / ShutterstockWilliam Ludwig was a 64-year-old retired corrections officer living in Bridgeton, New Jersey, in 2010, when he received a near-hopeless cancer prognosis. The Abramson Cancer Center at the University of Pennsylvania had run out of chemotherapeutic options, and Ludwig was disqualified from most clinical trials since he had three cancers at once—leukemia, lymphoma, and squamous cell skin cancer. In a later interview, the scientist Carl June described Ludwig’s condition as “Almost dead.” Alison Loren, an oncologist at Penn, had been taking care of Ludwig for five painful years. If chemotherapy is (...)

  • Delighted Health Insurance Executives Gather In Outdoor Coliseum To Watch Patient Battle Cancer - The Onion
    http://www.theonion.com/article/delighted-health-insurance-executives-gather-in-ou-35289

    According to reports, the policyholder, who was equipped with limited resources of his own during the fight, immediately faced the punishing and grave challenge of successfully submitting claims for a preliminary consultation with an out-of-network oncologist. As a slew of taunts and jeers rained down from the hordes of health insurance professionals, sources said the increasingly weary combatant suffered a crushing blow upon receiving a $60,000 bill for one week of inpatient care that exceeded his plan’s hospitalization coverage limit.

    A tense hush reportedly fell over the arena moments later when a CT scan showed the cancer on the brink of remission, though the stadium soon erupted into emphatic cheers when the patient was not approved for further sessions of targeted chemotherapy that were deemed “medically unnecessary.”

    “He’s putting up a pretty strong fight, but they really need to put an end to this soon—he’s starting to cost way more than he puts into his annual policy,” Humana executive vice president James E. Murray said as the patient, after making notable progress in obtaining a referral from his primary care physician, was instantly bombarded with an overwhelming barrage of indecipherable paperwork required to justify a follow-up appointment at his radiation therapy clinic.

  • Cancer drugs, survival, and ethics | The BMJ
    http://www.bmj.com/content/355/bmj.i5792.full
    La #chimiothérapie contribue très peu à la #survie des patients atteints de #cancer. Et elle coûte très cher.

    A meta-analysis published in 2004 explored the contribution of cytotoxic chemotherapy to five year survival in 250 000 adults with solid cancers from Australian and US randomised trials.3 An important effect was shown on five year survival only in testicular cancer (40%), Hodgkin’s disease (37%), cancer of the cervix (12%), lymphoma (10.5%), and ovarian cancer (8.8%). Together, these represented less than 10% of all cases. In the remaining 90% of patients—including those with the commonest tumours of the lung, prostate, colorectum, and breast—drug therapy increased five year survival by less than 2.5%—an overall survival benefit of around three months.3 Similarly, 14 consecutive new drug regimens for adult solid cancers approved by the European Medicines Agency provided a median 1.2 months overall survival benefit against comparator regimens.4 Newer drugs did no better: 48 new regimens approved by the US Food and Drug Administration between 2002 and 2014 conferred a median 2.1 month overall survival benefit.5 Drug treatment can therefore only partly explain the 20% improvement in five year survival mentioned above. Developments in early diagnosis and treatment may have contributed much more.6

    The approval of drugs with such small survival benefits raises ethical questions, including whether recipients are aware of the drugs’ limited benefits, whether the high cost:benefit ratios are justified, and whether trials are providing the right information.

  • Measuring #financial_toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) - Souza - 2016 - Cancer
    http://onlinelibrary.wiley.com/doi/10.1002/cncr.30369/full

    #Cancer and its treatment lead to increased financial distress for patients. To the authors’ knowledge, to date, no standardized patient-reported outcome measure has been validated to assess this distress.

    METHODS

    Patients with AJCC Stage IV solid tumors receiving chemotherapy for at least 2 months were recruited. Financial toxicity was measured by the COmprehensive Score for financial Toxicity (COST) measure.

    (...)

    CONCLUSIONS

    The COST measure demonstrated reliability and validity in measuring financial toxicity. Its correlation with HRQOL indicates that financial toxicity is a clinically relevant patient-centered outcome.

    #santé #finance #sécurité_sociale #États-Unis

  • Extremism & Incitement to Racial Hatred: Senior Israeli Officials in Their Own Words
    http://imeu.org/article/extremism-incitement-to-racial-hatred-senior-israeli-officials-in-their-own

    “A Jew always has a much higher soul than a gentile, even if he is a homosexual.”
    – Then-deputy minister of religious services and current deputy minister of defense, Rabbi Eli Ben-Dahan, 2013.

    “I am happy to be a fascist!”
    – Miri Regev, current minister of culture and sport, 2012.

    “[There are] 92,000 families in Israel in which one of the partners is not Jewish - we have a real problem that we have to deal with."
    – Tzipi Hotovely, current deputy foreign minister, 2011.

    “The Palestinian threat harbors cancer-like attributes that have to be severed. There are all kinds of solutions to cancer. Some say it’s necessary to amputate organs but at the moment I am applying chemotherapy.”
    – Then-general and current defense minister, Moshe Yaalon, 2002.

    “[The way to deal with Palestinians is to] beat them up, not once but repeatedly, beat them up so it hurts so badly, until it’s unbearable.”
    – Benjamin Netanyahu, current prime minister, while in the opposition following his first term as prime minister, caught on video speaking to Israeli settlers, 2001.

    #sionisme #sioniste #Israel #Israël #etat_raciste

  • Oncologist slams expensive chemo drugs at annual meeting | State Column
    http://www.statecolumn.com/2015/06/oncologist-slams-expensive-chemo-drugs-at-annual-meeting

    A top-level oncologist has just delivered a scathing critique of the exorbitant prices for many chemotherapy drugs at the annual meeting of the American Society for Clinical Oncology. According to Youth Health Magazine, Dr. Leanord Saltz, chief of gastrointestinal oncology at Memorial Sloan Kettering Cancer Center in New York went on a tirade against the ever-increasing cost of these critical medications during his speech at the meeting.

    Earlier during the day, representatives from pharmaceutical company Bristol-Meyers presented research that showed how a combination of two drugs they produced, Yervoy and Opdiva, significantly increased the length of lives in patients with melanoma. Saltz used the research as a starting point for his speech, noting that together they can cost a patient up to $295,000 each year.

    Saltz noted that the median monthly price for cancer drugs in the US has more than doubled in the past decade. The median price jumped from $4,716 each month from 2000 to 2004 to $ 9,900 each month between 2010 and 2014.

  • Sybille Paulsen uses cancer patients’ hair to form jewellery
    http://www.dezeen.com/2015/03/07/sybille-paulsen-cancer-patients-hair-chemotherapy-jewellery-tangible-truths

    Berlin-based designer Sybille Paulsen has worked with people undergoing chemotherapy treatment to create bespoke jewellery from their own hair.

    Sybille Paulsen’s Tangible Truths project enables cancer patients who cut off their hair, rather than lose it gradually as a result of chemotherapy treatment, to wear it in a different way.

    #design #cancer #Sybille_Paulsen

  • Breast Cancer Research | Full text | The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services
    Evans et al., Breast Cancer Research 2014, 16:442
    http://breast-cancer-research.com/content/16/5/442

    Abstract
    Introduction
    It is frequent for news items to lead to a short lived temporary increase in interest in a particular health related service, however it is rare for this to have a long lasting effect. In 2013, in the UK in particular, there has been unprecedented publicity in hereditary breast cancer, with Angelina Jolie’s decision to have genetic testing for the BRCA1 gene and subsequently undergo risk reducing mastectomy (RRM), and a pre-release of the NICE guidelines on familial breast cancer in January and their final release on 26th June. The release of NICE guidelines created a lot of publicity over the potential for use of chemoprevention using tamoxifen or raloxifene. However, the longest lasting news story was the release of details of film actress Angelina Jolie’s genetic test and surgery.

    Methods
    To assess the potential effects of the ‘Angelina Jolie’ effect, referral data specific to breast cancer family history was obtained from around the UK for the years 2012 and 2013. A consortium of over 30 breast cancer family history clinics that have contributed to two research studies on early breast surveillance were asked to participate as well as 10 genetics centres. Monthly referrals to each service were collated and increases from 2012 to 2013 assessed.

    Results
    Data from 12 family history clinics and 9 regional genetics services showed a rise in referrals from May 2013 onwards. Referrals were nearly 2.5 fold in June and July 2013 from 1,981 (2012) to 4,847 (2013) and remained at around two-fold to October 2013. Demand for BRCA1/2 testing almost doubled and there were also many more enquiries for risk reducing mastectomy. Internal review shows that there was no increase in inappropriate referrals.

    Conclusions
    The Angelina Jolie effect has been long lasting and global, and appears to have increased referrals to centres appropriately.

    Pour les photos de l’intéressée, voir les comptes-rendus dans la presse people…

    This is an Open Access article distributed under the terms of the Creative Commons Attribution License

  • Colo. girl banned from school after shaving head to support cancer-suffering pal allowed back in class - NY Daily News
    http://www.nydailynews.com/news/national/colo-child-kicked-school-shaving-head-sympathy-cancer-pal-article-1.173

    Nine-year-old Kamryn Renfro chose to go bald, with her parents’ approval, to show support for her friend battling cancer and undergoing chemotherapy. Caprock Academy sent her home Monday for violating the dress code, but allowed her back Tuesday after extensive media coverage.

  • Cancer, the Consummate Traveler - Issue 8: Home
    http://nautil.us/issue/8/home/cancer-the-consummate-traveler

    People may call cancer cells all sorts of derogatory names, but homebody isn’t one of them. Born into tumor cells, they relocate to surrounding tissues when their original homes become a toxic mess under the stress of their own overcrowding, the assault of chemotherapy, or when conditions elsewhere seem better. Some oncologists characterize the process of cancer’s spread throughout the body—called metastasis—as a kind of diaspora. And since 90 percent of cancer mortality involves some degree of metastasis, the details of the journey may help researchers strategize against the affliction. “In cancer circles, there’s a kind of dogmatic view: Here’s where cells start and end,” says Bruce Robertson, an ecologist at Bard College in Annandale-on-Hudson, New York. But this perspective ignores many (...)

  • The Rising Costs of Cancer Drugs — New York Magazine
    http://nymag.com/news/features/cancer-drugs-2013-10

    New drugs could extend cancer patients’ lives—by days. At a cost of thousands and thousands of dollars. Prompting some doctors to refuse to use them.

    Avastin, $5,000/month; Zaltrap, $11,000/month; Yervoy, $39,000/month; Provenge, $93,000/course of treatment; Erbitux, $8,400/month; Gleevec, $92,000/year; Tasigna, $115,000/year; Sprycel, $123,000/year.

    #cancer #big_pharma

    In 1965, at the dawn of Medicare, the chemotherapy drug Vinblastine cost $78 a month, according to a widely cited Sloan-Kettering price compendium. In 2011, Bristol-Myers Squibb introduced a new melanoma drug called Yervoy at a cost of about $38,000 a month for a three-month treatment.* Yervoy followed, by about a year, a new prostate-cancer therapy called Provenge that cost $93,000 per course of treatment. Even an ancient chemotherapy like nitrogen mustards, cousins to World War I’s mustard gas and in use since 1949, have gotten caught in the cost updraft; in 2006, a course of treatment experienced a thirteen­fold price increase, from $33 a month to $420 a month.

    (…)

    “What predicts the price of the next cancer drug is the price of the last cancer drug,” says Bach. “The only check on the system is corporate chutzpah.”

    (...)

    Just last week, a New England Journal of Medicine editorial characterized high drug prices as a form of “financial toxicity.”

    (...)

    “Whereas we had hoped that small, incremental gains would be a springboard to something bigger and more productive, I fear those small, incremental gains have become a business model. Right now, it is safer for a pharmaceutical company to strategize for large-scale clinical trials that look for small, incremental gains that will get a drug to market, than to swing for the fences and try for the big advance.”

    It’s not just that the skewed market for cancer drugs rewards mediocre products, he says. “Mediocrity is so well rewarded that it’s a better risk than aiming higher.”

    (...)

    Over the past decade, Kantarjian watched in disbelief as the cost of a successful leukemia drug called #Gleevec rose. “I was shocked that it had tripled since 2001,” he says, “and there was no reason for the increase in price, except that the companies could do it and nobody could do anything about it.” Kantarjian, as established a figure as there is in American oncology, suddenly became #radicalized.

    (...)

    Patients with cancer are 2.5 times as likely to declare bankruptcy as the general population

    (...)

    As a result [of #NICE], a British cancer patient usually pays substantially less than American patients. Gleevec costs about $33,500 a year in England, according to NICE; the U.S. price ranges up to $92,000 (according to the Blood editorial). Tasigna, a newer CML drug, costs about $51,000 in England, while the U.S. price ranges up to $115,000. Sprycel, another new CML drug, costs nearly $49,000 a year in England, while the U.S. price ranges up to $123,000.

    More to the point, NICE has recently said no where Medicare has been forced to say yes. In January 2012, NICE declined to approve Avastin for both colon and breast cancer, and last June, NICE reached the same conclusion about Zaltrap as Sloan-Kettering’s physicians—it declined to cover the use of the drug, considering it too expensive.

  • #Cancer Culture - S. Lochlann Jain
    https://anthropology.stanford.edu/people/lochlann-s-jain

    Usually cancer is studied as a distinct, finite, disease that some unfortunate people get. Nevertheless, over half of all Americans will be diagnosed with an invasive cancer. In this book, based in extensive analysis of the history, politics, and science of cancer, as well as years of fieldwork, I examine the ways that cancer is not separate from, but is central to medical, political, and social economies.

    lire en particulier “Be Prepared” et “Cancer Butch”

    • https://anthropology.stanford.edu/sites/default/files/jain.beprepared.pdf

      Did my mind declare war on my body ?

      J’ai passé un peu de temps pour mettre le pdf en texte ici (en OCR car ce sont des images du livre de mauvaise qualité), de manière à ce qu’il puisse être lu par les non anglophones. J’ai corrigé les premières pages, si j’ai le courage je ferais la suite au fur et à mesure.
      Dans tous les cas, ce texte méritait d’être diffusé, j’espère que l’auteur sera d’accord.

      I don’t blame people for not knowing how to engage with a person with cancer.
      How would they? Heck, I hadn’t either. Despite the fact that each
      year 70,000 Americans between the ages of fifteen and forty are diagnosed
      with the disease and that incidence in this age group has doubled in the last
      thirty years, many of my friends in their thirties have never had to deal with
      it on a personal level.

      I remember when my cousin Elise was undergoing chemotherapy treatment while in her early thirties. When I met her I couldn’t even mention it,
      couldn’t (or wouldn’t, or didn’t) say that I was sorry or ask her how it was
      going---even though it was so obviously the thing that was going on. I was
      thirty-five for God’s sake, a grown—up, a professional, a parent, and cancer
      was so unthinkable that I couldn’t even acknowledge her disease. When my
      former partner’s sister showed up at our house all bald after her chemotherapy, my only remark was, “Hey, you could totally be a lesbian.” I was terrified,
      or in denial. More likely I had picked up the culture of stigma and this disabled me from giving genuine acknowledgment. But whatever sympathetic spin you want to put on it, I sucked in all the ways that I had to learn how to deal with later. Indeed, an assumption of exceptionalism was only the flip side of my own shame.

      Fantasies of agency steep both sides of diagnosis. On the “previvor” side,
      images continually tell us that cancer can be avoided if you eat right, avoid
      Teflon and smoking, and come from strong stock. Alternatively, tropes of
      hope, survivorship, battling, and positive attitude are fed to people post-
      diagnosis as if they were at the helm of a ship in known waters, not along
      stormy and uncharted shores. And yet, so little of cancer science, patient
      experience, or survival statistics seems to provide backing for the ubiquitous
      calls for hope in the popular culture of cancer. After all, who would celebrate
      a survivor who did not stand amid at least a few poor SOBs who fell?

      Everyone who has "battled,” “been touched by,” “survived,” been “made
      into a shadow of a former self,” or has been called to inhabit the myriad can-

      170

      car cliches has been asked to live in a caricature. As poets say in rendering
      their craft, clichés serve to shut down meaning. Clichés allow us not to think
      about What we are describing or hearing about: we know roses are red. People
      with cancer are called to live in and through—even if recalcitrantly—these
      hegemonic clichés by news articles, TV shows, detection campaigns, patient
      pamphlets, high—tech protocol—driven treatments, hospital organizations and
      smells, and everyday social interactions. Such cultural venues as marches
      for hope, research funding and direction, pharmaceutical interests, survivor
      rhetoric, and hospital ads constitute not distinct cultural phenomena, but
      overlap to form a broader hegemony of ways that cancer is talked about and
      that in turn control and diminish the ways that cancer culture can be inhab-
      ited and spoken about. Cancer exceeds the biology of multiplying cells. But
      the paradoxes of cancer culture can also be used to reflect on broader Ameri—
      can understandings of health and the mismatch of normative assumptions
      with the ways people actually live and die. "lhe restricted languages of cancer
      are not innocent.

      For an example of how individuated agency is used in cancer, one might
      look to the massive literature and movement spurred by Bernard Siegel,
      which is based in the moral complex of cancer and what he describes as the
      “exceptional patient.” In Love, Medicine, and Miracles: Lessons Learned about
      Self—Healing from a Surgeon’s Experience with Exceptional Patients, Siegel
      writes about having the right attitude to survive cancer(1). In Siegel’s View and
      its variants, surviving cancer becomes a moral calling, as if dying indicates
      some personal failure. Siegel—style literature offers another form of torture
      to people with cancer: Did my mind declare war on my body? Am I a cold,
      repressed person? (Okay, don’t answer that.) This huge and punishing industry preys on fear as much as any in the cancer complex and adds guilt to the mix.
      As one woman with metastatic colon cancer said on a retreat I attended,
      “Maybe I haven’t laughed enough. But then I looked around the room and
      some of you laugh a lot more than I do and you’re still here.” She died a year
      later, though she laughed plenty at the retreat.

      It’s no wonder that shame is such a common response to diagnosis. The
      dictionary helps with a description of shame: “The painful emotion arising
      from the consciousness of something dishonoring, ridiculous, or indecorous in one’s own conduct or circumstances, or of being in a situation which
      offends one’s sense of modesty or decency.(2)” Indeed, cancer does offend. People in treatment are often advised to wear wigs and other disguises, to joke
      with colleagues; they are given tips on how to make others feel more at ease.
      One does want to present decency, to seem upbeat. And so do others. A quick

      171

      “you look good,” with a response of “oh, thanks,” offers a Welcome segue to
      the next discussion topic and enables a certain propriety to circumscribe the
      confusion of proper responses to illness, to the stigma embodied by the possibility of a short life and a painful death. One person with metastatic disease
      calls herself, semi-facetiously, “everyone’s worst nightmare.” Others Speak
      about how hard it is to see the celebration of survivors while knowing that
      they themselves are being killed by the disease.

      Social grace is a good thing. But given the scope of the disease --- half of all
      Americans die of it and many more go through treatment --- one might wonder what or whom such an astonishing cultural oversight serves. After all how can cancer, a predictable result of an environment drowning in indus:
      trial and military toxicity, be dishonoring or indecorous ? I don’t mean its
      side effects; the physical breakdown of the body is perhaps definitive of the
      word “indecorousf” But these pre- and post-diagnosis calls to disavowal can
      help illuminate the ugly underside of American’s constant will to health, its
      normative assumptions about health and the social) individual, and generational traumas that it propagates. Expectations and assumptions about life span and their discriminatory and generational effects offer but one of many venues for such an exploration.

      Survivorship in America

      Perhaps it’s a class issue, but I didn’t really think about survival until I was
      called to consider being in the position of the one who might be survived.
      I was just tootling along until I was invited by diagnosis to inhabit this category, to attend retreats, camps, and support groups, to share an infusion
      room—to do all kinds of things with many people who have not, in fact,
      survived cancer—and thus to survive them at their memorial services, the
      garage sales of their things> and in the constructing and reading of memorial
      Websites and obituaries.

      To be sure, cancer survivorship (as opposed to either cancer death or
      just plain survival) comes with its benefits. I got a free kayak, albeit with a
      leak. When things are going really wrong I think about how my life insur-
      ance could pay for some cool things for my kids, or that maybe I don’t have
      to worry about saving for a down payment since in order for a home to be
      , a good investment you should really plan to live in it for five years. Some-
      times,when you find yourself buying into those cancer mantras of living in
      the moment, you can look around from a superior place at all the people
      scurrying around on projects you have determined do not matter—and then

      172

      go and do the laundry or shop for groceries, just like everyone else. Or like
      Bette Davis does in the movie Dark Victory as she dies of a brain tumor; you
      can consider yourself the lucky one, not having to survive the deaths of those
      You love. You have that strange privilege of being able to hold the materiality
      of your own mortality up against every attempt to make value stick. You may
      Wonder, as I do, how anyone survives the death of a parent or a sibling or a
      close friend or lover—the things that are purportedly normal life events—
      until you go through it yourself.3

      On the other hand, it may be easy to devolve into the narcissism of unremitting fear.
      I like to keep in mind what a driver once told me when I asked
      him what it was like to drive celebrities such as Oprah Winfrey around New
      York He said, “They like to think they are important. But after every funeral
      I’ve been to, people do the saaaaame thing. They eat.”

      The doctor survives the clinical trial, the child survives the parent, the
      well survive the sick But how have we come to take this survivorship for
      granted, as something to which we are entitled? Even a century or two ago
      there would have been a good chance that several of us would have died in
      childbirth or of some illness. Devastating as it may have been, we would have
      expected this. And we don’t exactly live in a medical nirvana. The United
      States is not even in the top ten for the longevity of its population. In fact, the
      United States is missing from the top twenty or even thirty for longevity in
      the world. In some studies, it’s not even in the top forty.4 Despite this statistic,
      the United States spends more than any other nation on health care. Part of
      Americans’ dismal life expectancy results from the broad lack of access to
      health care as well as the broader and well-documented discrimination in
      health care against the usual suspects: African Americans, women, younger
      people, and queers. But other factors that afiect even those with excellent
      access to excellent care play in as well: the high levels of toxins in the environment, including those in human and animal bodies; cigarettes; guns; little
      oversight for food, automobile, and other product safety; high rates of medical error.

      In short, despite the insistent rhetoric of health, American economies
      simply do not prioritize it. That’s okay. There is no particular reason that the
      general health of a population should trump all other concerns. But given the
      evidence, how do we come to believe this disconnect between dismal health
      status in the United States and the entitlement to normative health and life
      span? What kind of management has this necessary disavowal required? And
      what about the obverse of this question: how do these stories constitute those
      who are forced to drop out? After all, if survival is a moral and financial

      173

      Figure 13.1: The 2006 “Put Your Lance Face On” campaign from American Century
      Investments. This version of the promotional photo omits the warning, required in print
      advertisement publications, that it is possible to lose money by investing (included in the
      original).

      expectation and entitlement, then mortality must be constituted as something outside of normal life, even though these early deaths pay for pension:
      and other deferred payments. Even though everyone will die. I hypothesize
      that stigma and shame offer a way to examine and challenge ideals of health
      and the Ways that normative life spans have been constructed.

      Accumulation

      For analytical wealth in this matter, nothing beats a recent advertisement for
      American Century Investments that featured Lance Armstrong (figure 13.1).

      Armstrong has provided something of a translational figure for the nexus
      of industry, cancer, and humanitarianism that constitutes the discourses of
      cancer survivorship, foregrounding and even heroizing cancer survivors. His
      own story relentlessly underpins this cultural work.

      174

      While some accounts of Armstrong’s success go so far as to credit chemotherapy for literally rebuilding his body as a cycling machine, and others link his drive and success to his cancer experience, Armstrong continually presents himself in public as a survivor, claiming that his greatest success and pride is having survived cancer. In his autobiography, It’s Not About the Bike, Armstrong describes how, when diagnosed with testicular cancer in 1996,
      he actively sought the best care available to overcome a poor prognosis. He
      chose a doctor Who offered a then-new treatment that turned out to revolutionize the treatment for testicular cancer, turning the disease from a highrisk cancer to a largely curable one even in its metastatic iteration. This coincidence in the timing of his disease and this new treatment has enabled him to make his own agency in finding medical care into another inspirational aspect of his cancer survival story.

      In fact, cancer treatments are some of the most rote, protocol-driven
      treatments in medical practice, perfect examples of what historian Charles
      Rosenberg has detected as the rationalization of disease and diagnosis at
      the expense of the humanness of individual patients.5 Yet Armstrong’s story
      serves several purposes. It overemphasizes the role of agency in the success
      of cancer treatment, a View that correlates well With the advertising messages
      of high—profile cancer centers. It overestimates the curative potential of treatments for most cancers, something we would all like to believe in. And it
      propagates the myth that everyone has the potential to be a survivor—even as, ironically, survivorship against the odds requires the deaths of others.

      This Armstrong story comes with real social costs for many people surviving with and dying of cancer. Mixiam Engelberg’s graphic novel, like so many cancer narratives, ends abruptly with the recurrence of her metastatic disease and her subsequent death. One prominent page other book has a cartoon with her holding a placard stating, “Lance had a different cancer,” in response to her friends’ and colleagues’ comparison of her With Armstrong and their terrifying denial of her actual situation.6 So, While many cancer survivors consider Armstrong an icon and inspiration, others feel that he is misrepresentative of the
      disease. He at once gives them impossible standards of survivorship while at
      the same time building his heroism on the high death rates of other cancers.

      The American Century Investments advertisement summons the reader
      to “Put Your Lance Face On.” After gazing into the close—up image of a determined looking Armstrong and thinking quietly to oneself, “What the fuck?”
      one reads that “putting on a Lance face” “means taking responsibility for your
      future. . . . It means staying focused and determined in the face of challenges.
      When it comes to investing . . .” This ad is about Lance the Cyclist, sure; it

      175

      is also about Lance the Cancer Survivor. Control over one’s future h
      together the common thread of cancer survival, Tour de France victor Olds
      smart investing. But all this folds into the tiny hedge at the bottom of tfieand
      Past performance is no guarantee of future results . . . it is possible to lad:
      money by investing.” Even the Lance Face can see only so far into the fumrose

      ’This warning, necessary by law, echoes a skill essential to living in cae:
      talism. In heij study of market traders, Caitlyn Zaloom finds that “a tradJ 1.
      must learn to manage both his own engagements with risk and the ph 31 Z
      sensations and social stakes that accompany the highs and lows of wignc
      and losing. . . . Aggressive risk taking is established and sustained by routiIlTig
      zation and bureaucracy; it is not an escape from it.”7 The conflation of Arm—
      strong as athlete and cancer survivor in this ad offers the perfect personifica-
      tion of market investing, since the healthy functioning of a capitalist orde;
      requires a valorization of focused determination and responsibility for one’s
      future. By now a truism, liberal economic and political ideals require citi—
      zens to place themselves within a particular masochistic relationship to time
      What else but an ethos of deferred gratification would allow such retirement
      plans to remain solvent?

      As offensive as this ad is in its use of disease to create business, Ann.
      Strong’s story constitutes a culturally acceptable version of courage, cancer
      and survival that serves to comfort a population With increasing cancer rates,
      and the ad puts to use and propagates these notions of survivorship. As one:
      person wrote about giving Armstrong’s autobiography to her mother as she
      was dying of cancer, “I wanted her to be a courageous ‘surVivor’ too. I think
      we find it less creepy or at least difficult When people assume the role of sur-
      vivor, where they pretend they’re going to live an easy and long life.”8

      You can be angry at cancer; you can battle cancer. One campaign under-
      written by a company that builds radiation technology even allows people to
      write letters to cancer. But to be angry at the culture that produces the dis-
      ease and disavows it as a horrible death is to be a poor sport, to not live up to
      the expectations of the good battle and the good death witnessed everywhere
      in cancer obituaries. A bad attitude of this genre certainly will never enable
      you to become an exceptional patient. It’s as though a death threat blackmails
      cancer anger and frustration. But more astonishing still is the way in which
      this “poor sport” characterization carries over even into other cancer events.

      There is nothing wrong With having fun while making money. As one
      under—forty person who has been living in the cancer complex for over tWO
      decades said, “A fundraiser is where you invite people to a big fun event,
      serve great drinks, and do everything oossible for them not to think about

      176

      cancer.”You do want people to feel good and strong so that they will open
      their wallets, but this humanitarian charity model (“Swim for women With
      cancerl”) obscures the politics and paradoxes of such divisions. As one per—
      son organizing a fundraiser for her particular and rare cancer said as she
      thought about asking her doctors to attend her event, “They’ve made enough
      money off my cancer, they could pay some back” I signed on as the mixolo—
      gist for the event and spent several hours designing circus—themed drinks

      with little cotton candy garnishes.

      Time and Accumulationv

      Armstrong’s class, gender, and curable cancer allow his iconic status to
      overshadow the simple fact that cancer can completely destroy your financial
      savings and your family’s future. Sixty percent of personal bankruptcies in
      the United States result from the high cost of health care.11 This news, won—
      derful for people working in the healthcare industry since many people wifl
      pay anything for medical goods and services, means that cancer can be a
      long, expensive disease, paid for over generations.

      When one’s financial planner asks, semi—ironically, how long you plan to
      five, he calls up the paradox of survivorship. Middle— and upper—class Ameri—
      cans are asked to plan for an assumed longevity, and to be sure, a properly
      planned life span combined With a little luck comes with its rewards. But in
      times of trouble, the language of financial service starts to show cracks, even
      for healthy youngish people. The other day, When interviewing a Fidelity rep—
      resentative about my decreasing retirement account, the representative kept
      using the phrase “as your retirement plan grows.” When I pointed out that it
      had, in fact, shrunk by 45 percent, he just stared at me blanldy.‘ When, as an
      experiment, I asked him about people who don’t make it to the age of sixty-
      five, he pleaded, “You really need to think about it as a retirement plan.”

      No matter how we are interpellated to think about these accounts, non—
      normative life spans tell us about the ways that capitalist notions of time and
      accumulation work both economically and culturally. Many kinds of eco—
      nomic benefits, for example, are based in an implied life span: you work now,
      and we’ll pay you later. Social Security benefits are granted on the basis of
      how much you have put into the system over the years, and they last until
      you or your survivors are no longer eligible. Middle-class jobs often include
      not only salaries, but what are known as “deferred payments.” Pensions fall
      into this category, as do penalty—free retirement savings, and the benefit some
      academics get of partial payment of their children’s tuition.

      177

      If you croak, some of these contributions may revert back to your estate;
      others may be disbursed to qualifying survivors; others Will be recycled into
      the plans that will pay for the education of your colleagues’ children. As With
      any insurance policy, such calculations require that the state or the employer
      offer salary packages in the form of a financial hedge on your mortality and
      calculate the averages over the Whole workforce. Payments for those Who
      get old depend on the fact that some will die young. It’s not personal; it’s
      statistical. ‘

      Actually, I take that back. I guess there is not much that is more per50na1
      than your sex life, and if
      you are heterosexual and married—that is, if you say
      you are sleeping with one person only and that person is of the opposite sex
      and over a certain age—your cancer card Will play more lucratively. If you
      fit these criteria, you may be able to pass on these benefits and enable your
      loved ones to pay off some of your medical debts or provide a way toward
      a more comfortable life in (and sometimes because of) your absence. The
      survivorship of a spouse is a state—endowed right, enabled in the form of a
      cash benefit and various forms of tax relief. A husband’s or Wife’s death will
      enable his or her spouse to receive Social Security checks for decades. This
      cash enables a sort of proxy—survival by fulfilling your responsibility toward
      the support of your spouse and possibly the support of your children.

      This is precisely how one person explained to me his reasoning behind
      a recent change of genders: he can now legally have a Wife, legally bring her
      into the country, and legally offer her the protections of Social Security. For
      the same reasons, my lawyer advised me to marry a man, so that my hus-
      band could give the survivor—cash to my girlfriend. For the same reasonS,
      my mother was bummed out When I turned out not to be straight. Health is
      social and institutional as well as physical. Capital and family legitimate and
      live through each other, in some sense rendering each other immortal.12

      Social Security might be seen as ensuring that those Who do not conform
      to its measures of social legitimacy—people with forms of support that do
      not fall into the marriage category—are not given the forms of security into
      Which they are asked to pay while they live. Straight marriage presents a form
      of cultural longevity for the institution of marriage, and the labor of those
      who cannot partake in such survivorship literally underwrites the security of
      the individuals who can.13

      Historians of marriage have documented how ideas about the well—being
      of children led to these forms of social support. But take a closer look, and
      you will see that it’s only some children who benefit from these protective
      policies. Here’s an example. My employer offers a housing benefit that gives

      178

      some employees financial assistance in purchasing a house. It also describes
      death as a “severed relationship.” The relationship between my employer and
      an employee of the university can pass through a surviving partner—they
      included same—seX couples in their benefits plan in 1992, alb eit as taxable ben—
      efits rather than the untaxed benefits that straight people receive#such that
      a surviving partner may continue to live in a house purchased with the help
      of this fringe benefit. However, if an employee has children and no partner,
      the relationship is severed and the children are “SOL” (shit out of luck); they
      must sell the house no matter what the market is like and return the down
      payment loan to the employer. The debt cycles of illness and the early deaths
      of a parent are thus differently borne out through what counts as legitimate
      survival, thus reinforcing and rewarding normative social structures.

      But more important to my argument here, these retirement and Social
      Security benefits offer one means by which the terms of life span come to
      be taken for granted by the middle class in the United States. They make life
      span into a financial and moral calling, albeit one that the state will be will—
      ing to partially subsidize in the event of the deaths of the citizens who fulfill
      its principles of economic and sexual responsibility

      All this rests on a premise critical to economies in America: time and
      accumulation go together. You need the former to get the latter, and you have
      more smfi as you get older. No wonder people want to freeze themselves.
      Seriously. Cryonics offers an obvious strategy to maximize capitalist accu—
      mulation. On my salary, I’ll be able to pay for my kids’ college tuition in one
      hundred and fifty years. If I could freeze myself and my daughters and let
      my savings grow over that time, then come back to life after all the work of
      accumulation has been done for me, well, I could take full advantage of both
      the deferral and the gratification.” This may sound ludicrous, but it’s basi-
      cally the next step of what is already happening; people already freeze their
      eggs and sperm in order to maintain their fertility to a point at Which they
      have gained the sort of financial security that time and accumulation (are
      supposed to) bring.

      While cryonics suspends biological life as capitalism proliferates, uncon-
      trollably duplicating cells work to immobilize biological life. Cancer paro-
      dies excess. It could not be farther from the metaphors of an external enemy
      attacking the body imagined by visions of targeted chemotherapy, the broad
      political imaginary of the war on cancer, or the trope of the courageously
      battling and graciously accepting patient. If wealth rots the soul, accumulat-
      ing tumors rot the host. It just grows, sometimes as a tumor you should have
      noticed but didn’t, sometimes as a tumor you can’t help but notice but can’t

      179

      remove. It may just live there; you may touch it each day. It may disappear 0r ‘-
      it may wrap its way around your tongue. Either way, its changing size may 7’,
      make it seem living or dying. It inhabits a competing version of time, not ,
      yours, to which such things as savings and retirement are supposed to cor. ’

      relate, but its own, to which such words as “a o tosis” and “runawa ” ,
      Y aCCrue.

      These versions of competing time reveal a lot about life spans in capitalism ,

      Conclusion

      Alas, the Lance Face aims not toward the growing demographic of cancer

      survivors whose bodies experience the fissures of the immortal pretensions of :

      economic time. Unlike manypeople who calculate their odds and cash out their

      retirement policies after diagnosis, or the friends of mine Who told me thatI L
      was the inspiration for them to live in the moment and renovate their home, or ~
      those ads that regularly appear in Cure magazine that offer to buy the life insux. 3
      ance policies of people with cancer in exchange for a percentage, the Lance ad;

      replays tiresome injunctions to future thinking, saving, and determination. :
      The ad encourages the potential consumer of banking products to workin the ;
      broader interests of capital. Simply put, the ad uses cancer for its own ends and ’

      is able to do so because of the way that cancer rhetorics have so unquestion—
      ingly oyerlapped With notions of progress and accumulation in capitalism.

      The cultural management of cancer terror follows to some extent the,
      Cold War strategies of damping nuclear terror. You may have wondered why

      the phrase “you are the bomb” presents itself as something of a compliment

      Whereas, in a romantic situation, the comment “you are the gas chamber”,
      may not go over that well. Anthropologist Joseph Masco has analyzed how

      Americans didn’t just turn the threat of nuclear annihilation into atomic

      cafes, bikinis, and B—sz cocktails on their own; we were taught to survive

      through specific governmental programs sought to manage the emotional
      politics of the bomb. Nuclear terror, as a paralyzing emotion, was converted
      into nuclear fear, “an affective state that would allow citizens to function
      in a time of crisis.”5 Such emotional management required a two-pronged
      approach. First, citizens were asked to “take responsibility for their own
      survival.” Second, enemy status was displaced from nuclear war onto public
      panic, such that the main threat was perceived as inappropriate reactions to‘
      detonation, rather than to the bomb itself. Even With increased bomb testing
      and its release of radiation into the atmosphere, the discovery of high levels
      of radiation in American flesh and teeth, and the corresponding increasing
      of cancer rates along fallout routes and among nuclear workers, the nuclear

      180

      threat was always constituted as coming from the outside, never as the pre-
      dictable and calculated risk of American nuclear programs. In that sense, the
      forms of emotional management that resulted from military technologies
      underpin cancer culture in the United States as much as the technologies of
      Chemotherapy and radiation do.

      To be sure, the increasing use of the language of survivorship in main—
      stream cancer culture offers a welcome change from the days when people
      with cancer were asked to use plastic cutlery so as not to infect those around
      them or were not told of their diagnoses in order to protect them. Now, the
      Person who survives cancer walks a fine line between courage and deception,
      horror and the quotidian, in ensuring that American models of health retain
      their normative status. Lance Armstrong offers the perfect venue for such
      disavowals, as he currently rises as if in a second coming, high above the
      Nike building at Union Square in San Francisco and other American cities,
      his Lance face in perfect shape, With another sufficiently vague, sportsmanly
      tag line: “Hope Rides Again.”

      What if, instead of some broad and grammatically, if not afiectiyely,
      meaningless aim as marching and riding “for hope,” fundraisers attempted to
      ban any one of the thousands of known carcinogens in legal use? What if we
      walked, ran, swam, rode not for hope, but against PAH, MTBE, EPA or any
      other common carcinogen? Such an effort would require naming. the prob—
      lem rather than the symptom, and recognizing how we are all implicated. It

      would require that we invest in cancer culture not as a node of sentimentality
      but as a basic fact of American life.

      NOTES

      1. Bernie S. Siegel, Love, Medicine, and Miracles: Lessons Learned about Ser—Healing
      from a Surgeon’s Experience with Exceptional Patients (New York: Harper and Row, 1986).

      2. Oxford English Dictionary, 2nd ed., s.v. “Shame.”

      3. Again, I think it is easier to speak facetiously from the position of having a non—
      metastatic diagnosis.

      4. Stephen Ohlemachter, “US Slipping in Life Expectancy Rankings,” Wash—
      ington Post, August 12, 2007, httpzllwww.washingtonpost.com/wp—dyn/content/arti-
      c1e/2007/ 08/12/AR2007081200113html.

      5. See Charles E. Rosenberg, “The Tyranny of Diagnosis: Specific Entities and Indi—
      vidual Experience,” The Milbank Quarterly 80, no. 2 (June 2002): 237—60.

      6. Miriam Engelberg, Cancer Made Me a shallower Person (New York: Harper,
      2006).

      7. Caitlin Zaloom, “The Productive Life of Risk,” Cultural Anthropology 19, no. 3
      (Angust 2004): 365.

      181

      8. Personal correspondence with author, April 10, 2008.

      9. Personal correspondence with author, March 15, 2009.

      10. Personal correspondence with author, April 11, 2009.

      11. See David U. Himmelstein, Deborah Thorne, Elizabeth Warren, and Steflie W001-
      handler, “Medical Bankruptcy in the United States, 2007: Results of a National Study)” "me
      American Journal ofMedicz’ne 122, no. 8 (August 2009): 741—46. -

      12. These structures carry invisible costs even for straight people Who believe
      themselves to be outside of these cycles. Think for example of the shooting of Harvey
      Milk and George Moscone. The short sentence given to Dan White for the shooting is
      usually ascribed to the fact that, since Milk was queer, the judge believed that his life Was
      not worth much. Moscone Was considered collateral damage. See The Times of Harvey
      Milk, dir. Rob Epstein, 90 min, Black Sand Productions, 1984.

      13. This kind of structural attention to cultural institutions and actual care are
      understudied For example, When President Barack Obama made an exception to his i
      usual homophobic platform to call for allowing same-sex couples to be able to visit their
      partners in hospitals, he was making a way for partners to be able to love each other
      and to be able to share a deep experience. Advocacy and protection are huge parts of
      contemporary medical care. I have eome across hundreds of examples of this in my years
      of research. This aspect of contemporary medical care includes everything from making
      sure that medical records are transferred properly or read, that medical allergies are made
      known, that machinery is working, that people wash their hands and are given the proper
      doses of medication. Such bedside advocacy is an enormous, and understadiei part of
      healthcare provision.

      14. Tiffany Romain is working on an important dissertation on this subject in the
      Department of Anthropology at Stanford University.

      15. Joseph Masco, “Survival Is Your Business: Engineering Ruins and Affect in Nuclear
      America,” Cultural Anthropology 23, no. 2 (May 2008): 366.

      182

  • Drugs shortages: Can’t wait? Must wait | The Economist
    http://www.economist.com/node/21536593

    This year has seen a shortage of 232 medicines, up from 70 in 2006, according to the University of Utah, which keeps the country’s most comprehensive list. These are mostly injected medicines, such as generic chemotherapy drugs. Many patients have had to delay treatment. A grey market has flourished, with middlemen hoarding drugs and selling them at a premium.

    #santé #cancer #pharma #économie #etats-unis